Items related to Medical Eligibility Criteria for Contraceptive Use
This book is one important step in a process for improving access to quality of care in family planning. The WHO Medical Eligibility Criteria for Contraceptive Use, Fifth Edition, continues the series of periodic updates of guidance on the safety of various contraceptive methods for use in the context of specific health conditions and characteristics. The recommendations contained within this book are based on the latest clinical and epidemiological data.
The intended audience for this publication includes policymakers, family planning program managers and the scientific community. It provides guidance to national family planning/reproductive health programs in the preparation of guidelines for service delivery of contraceptives. Several tools and job aids are available from WHO and other sources to help providers use these recommendations in practice.
The book covers the following family planning methods: lowdose (35 mcg ethinyl estradiol) combined oral contraceptives (COCs), combined patch (P), combined vaginal ring (R), combined injectable contraceptives (CICs), progestogen-only pills (POPs), depot medroxy-progesterone acetate (DMPA), norethisterone enantate (NET-EN), levonorgestrel (LNG) and etonogestrel (ETG) implants, emergency contraceptive pills (ECPs), copper-bearing intrauterine devices (Cu-IUDs), levonorgestrel-releasing IUDs (LNG-IUDs), copper-IUD for emergency contraception (E-IUD), barrier methods (BARR), fertility awareness-based methods (FAB), lactational amenorrhoea method (LAM), coitus interruptus (CI), and female and male sterilization (STER).
The goal of this document is to provide policy-makers, decision-makers, and the scientific community with a set of recommendations that can be used for developing or revising national guidelines on medical eligibility criteria for contraceptive use. The document does not provide rigid guidelines but rather gives recommendations that provide a basis for rationalizing the provision of various contraceptives in view of the most up-to-date information available on the safety of the methods for people with certain health conditions.
The intended audience for this publication includes policymakers, family planning program managers and the scientific community. It provides guidance to national family planning/reproductive health programs in the preparation of guidelines for service delivery of contraceptives. Several tools and job aids are available from WHO and other sources to help providers use these recommendations in practice.
The book covers the following family planning methods: lowdose (35 mcg ethinyl estradiol) combined oral contraceptives (COCs), combined patch (P), combined vaginal ring (R), combined injectable contraceptives (CICs), progestogen-only pills (POPs), depot medroxy-progesterone acetate (DMPA), norethisterone enantate (NET-EN), levonorgestrel (LNG) and etonogestrel (ETG) implants, emergency contraceptive pills (ECPs), copper-bearing intrauterine devices (Cu-IUDs), levonorgestrel-releasing IUDs (LNG-IUDs), copper-IUD for emergency contraception (E-IUD), barrier methods (BARR), fertility awareness-based methods (FAB), lactational amenorrhoea method (LAM), coitus interruptus (CI), and female and male sterilization (STER).
The goal of this document is to provide policy-makers, decision-makers, and the scientific community with a set of recommendations that can be used for developing or revising national guidelines on medical eligibility criteria for contraceptive use. The document does not provide rigid guidelines but rather gives recommendations that provide a basis for rationalizing the provision of various contraceptives in view of the most up-to-date information available on the safety of the methods for people with certain health conditions.
"synopsis" may belong to another edition of this title.
About the Author:
World Health Organization is a Specialized Agency of the United Nations, charged to act as the world's directing and coordinating authority on questions of human health. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries, and monitoring and assessing health trends.
"About this title" may belong to another edition of this title.
- PublisherWorld Health Organization
- Publication date2015
- ISBN 10 9241549157
- ISBN 13 9789241549158
- BindingPaperback
- Number of pages272
Buy New
Learn more about this copy
US$ 76.58
Shipping:
US$ 11.24
From Ireland to U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
Medical Eligibility Criteria for Contraceptive Use
Published by
World Health Organization
(2015)
ISBN 10: 9241549157
ISBN 13: 9789241549158
New
Softcover
Quantity: 2
Seller:
Rating
Book Description Condition: New. Num Pages: 272 pages, chiefly tables. BIC Classification: KCL; MBNH. Category: (P) Professional & Vocational. Dimension: 300 x 208 x 15. Weight in Grams: 1021. . 2015. 5 Rev ed. Paperback. . . . . Seller Inventory # V9789241549158
Buy New
US$ 76.58
Convert currency
Stock Image
Medical Eligibility Criteria for Contraceptive Use
Published by
World Health Organization
(2015)
ISBN 10: 9241549157
ISBN 13: 9789241549158
New
Softcover
Quantity: 2
Seller:
Rating
Book Description Condition: New. Num Pages: 272 pages, chiefly tables. BIC Classification: KCL; MBNH. Category: (P) Professional & Vocational. Dimension: 300 x 208 x 15. Weight in Grams: 1021. . 2015. 5 Rev ed. Paperback. . . . . Books ship from the US and Ireland. Seller Inventory # V9789241549158
Buy New
US$ 92.91
Convert currency